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We thank Alain Braillon for his 
comments on our study on alcohol 
use disorders and dementia in France.1 
It opened up the discussion beyond 
the results of this study, which 
had to be restricted to alcohol use 
disorders, as our study was based on 
hospital records and did not include 
information on reported levels of 
alcohol consumption.
Braillon is right: systematic reviews2 
as well as large studies, including 
neuroimaging studies,3 show that 
moderate alcohol consumption is 
linked to functional and structural 
impairments of the brain. This effect 
was found primarily in studies of 
people under the age of 65 years, 
whereas in studies focusing on older 
people results are more ambiguous. 
Future research is necessary to 
identify reasons for the seemingly 
different effects of alcohol use 
disorders for different ages (eg, 
by full adjusting for the effect of 
competing risks on premature death, 
or analysing the potential interactions 
between risk factors). However, 
we would like to point out that 
neuroimaging studies, such as that of 
Topiwala and colleagues,3 which used 
multiple measurements of exposure, 
validated specific outcomes, and large 
population-based samples with high 
follow-up rates, provide stronger 
evidence than most of the studies in 
the field, which use only one measure 
of exposure, often failing to exclude 
sick-quitters, and unspecific outcomes. 
Thus, decision makers should rather 
base our policies on the precautionary 
principle and initiate proven effective 
and cost-effective measures to 
reduce overall consumption, such as 
WHO’s best buys (ie, higher taxation, 
restrictions on availability, and a ban on 
advertising and marketing of alcohol).4
Even though our results regarding 
the effect of alcohol use disorders 
as the largest risk factor for all types 
of dementia need to be confirmed, 
decision makers should additionally 
implement preventive measures 
for heavy drinking, such as brief 
interventions or early treatment at 
the primary care level.5 As for future 
research, if it was possible to include 
alcohol use measures routinely in 
hospital charts, this would give us 
much better evidence on the impact 
of alcohol use for the full continuum of 
use patterns and would help improve 
our understanding of the association 
between alcohol use and dementia 
dramatically.
We declare no competing interests.
Copyright © 2018 The Author(s). Published by 
Elsevier Ltd. This is an Open Access article under the 
CC BY-NC-ND 4.0 license. 




Translational Health Economics Network, Paris, 
France and Infection, Antimicrobials, Modelling, 
Evolution, UMR 1137,INSERM, Université Paris 
Diderot, Sorbonne Paris Cité, Paris, France (MS); 
INSERM, University of Bordeaux, and 
U1219-Bordeaux Population Health, 
ISPED-Bordeaux School of Public Health, Bordeaux, 
France (CD); Bordeaux University Hospital, 
Public Health Department, Medical Information 
Service, Bordeaux, France (CD); Dalla Lana School of 
Public Health, Institute of Medical Science, and 
Department of Psychiatry University of Toronto, 
Toronto, ON, Canada (JR); Campbell Family Mental 
Health Research Institute, and Institute for Mental 
Health Policy Research, CAMH, Toronto, ON, Canada 
(JR); and Institute for Clinical Psychology and 
Psychotherapy, Technische Universität Dresden, 
Dresden, Germany (JR) 
1 Schwarzinger M, Pollock BG, Hasan OSM, 
Dufouil C, Rehm J. Contribution of alcohol use 
disorders to the burden of dementia in France 
2008–13: a nationwide retrospective cohort 
study. Lancet Public Health 2018; 3: e124–32.
2 Verbaten MN. Chronic effects of low to 
moderate alcohol consumption on structural 
and functional properties of the brain: 
beneficial or not? Hum Psychopharmacol 2009; 
24: 199–205.
3 Topiwala A, Allan CL, Valkanova V, et al. 
Moderate alcohol consumption as risk factor 
for adverse brain outcomes and cognitive 
decline: longitudinal cohort study. BMJ 2017; 
357: j2353.
4 Chisholm D, Moro D, Bertram M, et al. Are the 
“best buys” for alcohol control still valid? An 
update on the comparative cost-effectiveness 
of alcohol control strategies at the global level. 
J Stud Alcohol Drugs 2018 (in press). 
5 Rehm J, Anderson P, Manthey J, et al. 
Alcohol use disorders in primary health care: 
what do we know and where do we go? 
Alcohol Alcohol 2016; 51: 422–27.
